Generated August 27, 2026 at 8:33 PM ET
· Covers August 27 trading day
· 10 of 169 ready 8-Ks selected
· AI-assisted overview
Today's filings featured several major corporate actions. Bleichroeder completed its business combination with Pasqal, and Forte Biosciences was acquired by argenx for $2.2 billion. On the regulatory front, SOBR Safe and Rein Therapeutics received Nasdaq delisting notices, while Live Ventures saw SEC claims dismissed. In earnings, Build-A-Bear cut its outlook after a weak quarter, while Gap raised its EPS guidance. Additionally, Solstice and Element Solutions terminated their merger, and Kuber Resources announced a CFO change amid a dispute.
KUBR
Kuber Resources Corp
leadership
negative
materiality 0.85
August 27, 2026, 9:30 AM ET
Kuber Resources CFO Li Jiyong resigns amid dispute; Raymond Fu named CFO; 10-K delayed
- Li Jiyong resigned as director and CFO effective April 10, 2026, citing alleged breach of Oct 16, 2025 agreement and disagreements with management.
- Company disputes Li's claims and reserves rights to investigate his tenure as CFO.
- Raymond Fu appointed CFO effective Aug 21, 2026; he remains CEO, President, Secretary, Treasurer, and director.
regulatory
negative
materiality 0.85
August 27, 2026, 5:00 PM ET
SOBR Safe faces Nasdaq delisting for equity deficiency; director resigns
- Nasdaq notified SOBR on Aug 21, 2026 that stockholders' equity fell below $2.5M minimum per Rule 5550(b)(1).
- Company also fails bid price requirement; cumulative reverse splits 1-for-1100 make it ineligible for 180-day compliance period.
- Hearings panel granted continued listing until Sept 15, 2026, contingent on closing business combination with Clean World Ventures, Inc.
BBCQ
Bleichroeder Acquisition Corp. II
M&A
positive
materiality 0.90
August 27, 2026, 4:20 PM ET
Bleichroeder completes business combination with Pasqal; shares to trade as PSQL
- Business combination closed Aug 27, 2026; surviving company renamed Pasqal Holding SA.
- Ordinary shares and warrants to trade on Nasdaq as PSQL and PSQLW starting Aug 28, 2026.
- Approximately $360M cash available at closing to fund quantum computing expansion.
RNTX
Rein Therapeutics, Inc.
regulatory
negative
materiality 0.80
August 27, 2026, 4:05 PM ET
Rein Therapeutics receives Nasdaq delisting notice for bid price below $1.00
- Received delisting notice from Nasdaq on Aug 21, 2026 for bid price below $1.00 for 30 consecutive trading days.
- Has 180 days, until Feb 17, 2027, to regain compliance with minimum bid price rule.
- Must achieve closing bid of at least $1.00 for 10 consecutive business days to cure.
SOLS
Solstice Advanced Materials Inc.
M&A
positive
materiality 0.80
August 27, 2026, 5:18 PM ET
Solstice and Element Solutions mutually terminate merger; $500M buyback, FY26 guidance reaffirmed
- Mutual termination of merger agreement with Element Solutions (ESI); no fees payable by either party.
- Board authorized $500M share repurchase program; 158,889,436 shares outstanding as of Aug 26, 2026.
- Reaffirmed FY2026 guidance: net sales $4,125-4,185M, adj EBITDA $1,035-1,055M, adj EPS $2.75-2.95.
regulatory
positive
materiality 0.80
August 27, 2026, 1:00 PM ET
SEC dismisses all claims against Live Ventures; CEO Isaac settles for $175k
- U.S. District Court for Nevada dismissed all SEC claims against Live Ventures; no judgment, penalty, or findings against company.
- Case No. 2:21-cv-01433-JCM-MDC; SEC investigation began late 2017, suit filed Aug 2021, summary judgment denied Feb 2026.
- CEO Jon Isaac entered consent judgment resolving individual claims, paying $175,000 civil penalty; he denies all allegations.
FBRX
Forte Biosciences, Inc.
M&A
neutral
materiality 1.00
August 27, 2026, 4:15 PM ET
Forte Biosciences acquired by argenx for $77.00/share, ~$2.2B; delisting planned
- Tender offer accepted 19,894,879 shares (~87.13% of outstanding) at $77.00/share cash.
- Merger completed Aug 27, 2026; Forte is now a wholly owned subsidiary of argenx BV.
- Total consideration ~$2.2B funded from argenx cash; covers options, RSUs, warrants.
BBW
BUILD-A-BEAR WORKSHOP INC
earnings
negative
materiality 0.85
August 27, 2026, 6:55 AM ET
Build-A-Bear Q2 revenue down 7.2%, EPS $0.70; cuts FY26 outlook
- Q2 total revenues $115.3M vs $124.2M prior; pre-tax income $11.6M vs $15.3M; diluted EPS $0.70 vs $0.94.
- FY26 revenue outlook lowered to $500-525M; pre-tax income lowered to $60-68M, includes ~$13M IEEPA tariff refund.
- CFO David Henderson terminated without cause Aug 26, 2026; gets $501,500 severance plus benefits.
BNET
BION ENVIRONMENTAL TECHNOLOGIES INC
debt
negative
materiality 0.70
August 27, 2026, 4:06 PM ET
Bion settles lease dispute with $162.5K convertible note; lease payments suspended
- Bion issued $162,500 convertible promissory note to landlord North Prairie Holdings for delinquent rent at Fair Oaks facility.
- Note bears 10% interest, matures Jan 3, 2027 or upon $2M+ qualified financing; converts at financing price.
- Monthly $6,250 lease payments suspended and added to note principal until maturity or financing.
earnings
positive
materiality 0.80
August 27, 2026, 4:22 PM ET
Gap Q2 beats profit expectations, raises FY EPS outlook; Old Navy CEO transition
- Net sales $3.7B, down 2% YoY; comparable sales -1%; store sales -3%, online -1%.
- Adjusted operating income $259M (7.1% margin) vs expectations; reported operating income $676M incl. IEEPA tariff recovery.
- Adjusted EPS $0.52; net income $501M, diluted EPS $1.38; raised FY EPS outlook.